Suppr超能文献

检测孕妇血液中的抗 HLA 抗体,以识别有抗体介导的母体抗胎儿排斥和自发性早产风险的患者。

Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.

机构信息

Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, USA.

出版信息

Am J Reprod Immunol. 2013 Aug;70(2):162-75. doi: 10.1111/aji.12141.

Abstract

PROBLEM

Maternal anti-fetal rejection is a mechanism of disease in spontaneous preterm labor. The objective of this study was to determine whether the presence of human leukocyte antigen (HLA) panel-reactive antibodies (PRA) during the second trimester increases the risk of spontaneous preterm delivery.

METHODS OF STUDY

This longitudinal case-control study included pregnant women with spontaneous preterm deliveries (n = 310) and control patients with normal term pregnancies (n = 620), matched for maternal age and gravidity. Maternal plasma samples obtained at 14-16, 16-20, 20-24, and 24-28 weeks of gestation were analyzed for HLA class I and class II PRA positivity using flow cytometry. The fetal HLA genotype and maternal HLA alloantibody epitope were determined for a subset of patients with positive HLA PRA.

RESULTS

(i) Patients with spontaneous preterm delivery were more likely to exhibit HLA class I (adjusted OR = 2.54, P < 0.0001) and class II (adjusted OR = 1.98, P = 0.002) PRA positivity than those delivering at term; (ii) HLA class I PRA positivity for patients with spontaneous preterm delivery between 28 and 34 weeks (adjusted OR = 2.88; P = 0.001) and after 34 weeks of gestation (adjusted OR = 2.53; P < 0.0001) was higher than for those delivering at term; (iii) HLA class II PRA positivity for patients with spontaneous preterm delivery after 34 weeks of gestation was higher than for those delivering at term (adjusted OR = 2.04; P = 0.002); (iv) multiparous women were at a higher risk for HLA class I PRA positivity than nulliparous women (adjusted OR = 0.097, P < 0.0001 for nulliparity); (v) nulliparous women had a higher rate of HLA class I PRA positivity with advancing gestational age (P = 0.001); and (vi) 78% of women whose fetuses were genotyped had alloantibodies specific against fetal HLA class I antigens.

CONCLUSION

Pregnant women with positive HLA class I or class II PRA during the second trimester are at an increased risk of spontaneous preterm delivery due to antibody-mediated maternal anti-fetal rejection.

摘要

问题

母体对胎儿的排斥是自发性早产的一种疾病机制。本研究的目的是确定在妊娠中期是否存在人类白细胞抗原(HLA)面板反应性抗体(PRA)会增加自发性早产的风险。

方法

这项纵向病例对照研究纳入了自发性早产(n=310)和正常足月妊娠(n=620)的孕妇,根据母亲年龄和孕次进行匹配。在妊娠 14-16、16-20、20-24 和 24-28 周时采集孕妇血浆样本,使用流式细胞术分析 HLA Ⅰ类和Ⅱ类 PRA 阳性。对于 HLA PRA 阳性的部分患者,确定胎儿 HLA 基因型和母体 HLA 同种异体抗体表位。

结果

(i)与足月分娩的患者相比,自发性早产患者更有可能出现 HLA Ⅰ类(调整后的 OR=2.54,P<0.0001)和Ⅱ类(调整后的 OR=1.98,P=0.002)PRA 阳性;(ii)28-34 周(调整后的 OR=2.88;P=0.001)和 34 周后(调整后的 OR=2.53;P<0.0001)自发性早产患者的 HLA Ⅰ类 PRA 阳性率高于足月分娩的患者;(iii)34 周后自发性早产患者的 HLA Ⅱ类 PRA 阳性率高于足月分娩的患者(调整后的 OR=2.04;P=0.002);(iv)与初产妇相比,多产妇 HLA Ⅰ类 PRA 阳性的风险更高(调整后的 OR=0.097,P<0.0001,初产妇);(v)初产妇随着妊娠周数的增加,HLA Ⅰ类 PRA 阳性率更高(P=0.001);(vi)78%的胎儿进行基因分型的患者存在针对胎儿 HLA Ⅰ类抗原的同种抗体。

结论

妊娠中期 HLA Ⅰ类或Ⅱ类 PRA 阳性的孕妇发生自发性早产的风险增加,原因是抗体介导的母体对胎儿的排斥。

相似文献

5
Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?
Am J Reprod Immunol. 2013 Oct;70(4):285-98. doi: 10.1111/aji.12143. Epub 2013 Aug 1.
9
Comparison of Anti-HLA Antibody Production According to Gestational Periods in Pregnant Women.
Transplant Proc. 2017 Apr;49(3):464-466. doi: 10.1016/j.transproceed.2017.01.011.
10
[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Hum Immunol. 2005 May;66(5):526-34. doi: 10.1016/j.humimm.2004.12.007. Epub 2005 Feb 12.

引用本文的文献

1
Proteomic Profiles of Maternal Plasma Extracellular Vesicles for Prediction of Preeclampsia.
Am J Reprod Immunol. 2024 Oct;92(4):e13928. doi: 10.1111/aji.13928.
2
Immunologic aspects of preeclampsia.
AJOG Glob Rep. 2024 Feb 9;4(1):100321. doi: 10.1016/j.xagr.2024.100321. eCollection 2024 Feb.
3
Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment.
Am J Obstet Gynecol. 2024 Mar;230(3S):S807-S840. doi: 10.1016/j.ajog.2023.02.002. Epub 2023 Mar 21.
5
Memory B Cells in Pregnancy Sensitization.
Front Immunol. 2021 Jun 30;12:688987. doi: 10.3389/fimmu.2021.688987. eCollection 2021.
6
Epidemiology of Pregnancy Complications Through the Lens of Immunological Memory.
Front Immunol. 2021 Jun 25;12:693189. doi: 10.3389/fimmu.2021.693189. eCollection 2021.
7
Recent Insights on the Maternal Microbiota: Impact on Pregnancy Outcomes.
Front Immunol. 2020 Oct 23;11:528202. doi: 10.3389/fimmu.2020.528202. eCollection 2020.
8
Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection?
Am J Reprod Immunol. 2021 Mar;85(3):e13373. doi: 10.1111/aji.13373. Epub 2020 Nov 24.
9
MAIT Cells at the Fetal-Maternal Interface During Pregnancy.
Front Immunol. 2020 Aug 19;11:1788. doi: 10.3389/fimmu.2020.01788. eCollection 2020.

本文引用的文献

2
A glow of HLA typing in organ transplantation.
Clin Transl Med. 2013 Feb 23;2(1):6. doi: 10.1186/2001-1326-2-6.
3
Decidual regulatory T cells in placental pathology and pregnancy complications.
Am J Reprod Immunol. 2013 Jun;69(6):533-8. doi: 10.1111/aji.12077. Epub 2013 Feb 6.
6
Inducing tolerance to pregnancy.
N Engl J Med. 2012 Sep 20;367(12):1159-61. doi: 10.1056/NEJMcibr1207279.
7
The major histocompatibility complex in transplantation.
J Transplant. 2012;2012:842141. doi: 10.1155/2012/842141. Epub 2012 Jun 20.
10
Regulatory T helper cells in pregnancy and their roles in systemic versus local immune tolerance.
Am J Reprod Immunol. 2011 Jul;66 Suppl 1:31-43. doi: 10.1111/j.1600-0897.2011.01049.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验